Stocks · News reference
On Friday, Trulieve Cannabis (NYSE:TRLV) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Trulieve Cannabis Corp. announced that its Chief Corporate Affairs and Strategy Officer, Christine Hersey, will participate in a panel discussion at the upcoming IgniteIt Cannabis Capital & Policy Summit.
Trulieve Cannabis Corp. has launched a new medical cannabis kiosk at Riverside Pharmacy in Gainesville, Georgia, to provide qualified patients with increased access to its products.
Trulieve Cannabis Corp. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $230.2 million and adjusted earnings per share of $0.09.
Filed: 2026-11-05 AccNo: 0001754195-26-000087 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Cantor Fitzgerald has reaffirmed its "Overweight" rating and $15 price target for Trulieve Cannabis Corp.
Trulieve Cannabis Corp. has been granted federal registrations by the U.S. Drug Enforcement Administration for its state-licensed medical marijuana dispensaries.